Cadila Healthcare informs about press release

21 Jan 2019 Evaluate

Cadila Healthcare has informed about submission of a copy of press release dated January 21, 2019 titled ‘Zydus receives tentative approval from the USFDA for Esomeprazole Magnesium Delayed-Release Capsules USP’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

881.95 -2.90 (-0.33%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×